These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 7690250

  • 1. Differential modulation of P-glycoprotein transport by protein kinase inhibition.
    Bates SE, Lee JS, Dickstein B, Spolyar M, Fojo AT.
    Biochemistry; 1993 Sep 07; 32(35):9156-64. PubMed ID: 7690250
    [Abstract] [Full Text] [Related]

  • 2. Regulation by phorbol ester and protein kinase C inhibitors, and by a protein phosphatase inhibitor (okadaic acid), of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug-resistant human KB cells.
    Chambers TC, Zheng B, Kuo JF.
    Mol Pharmacol; 1992 Jun 07; 41(6):1008-15. PubMed ID: 1377325
    [Abstract] [Full Text] [Related]

  • 3. Effects of protein kinase C modulators on multidrug resistance in human glioma cells.
    Matsumoto T, Tani E, Yamaura I, Miyaji K, Kaba K.
    Neurosurgery; 1995 Mar 07; 36(3):565-71; discussion 572. PubMed ID: 7538636
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of rhodamine 123 secretion by cyclosporin A as a model of P-glycoprotein mediated transport in liver.
    Stapf V, Thalhammer T, Huber-Huber R, Felberbauer F, Gajdzik L, Graf J.
    Anticancer Res; 1994 Mar 07; 14(2A):581-5. PubMed ID: 7912496
    [Abstract] [Full Text] [Related]

  • 5. Loss of cyclosporin and azidopine binding are associated with altered ATPase activity by a mutant P-glycoprotein with deleted phe(335).
    Chen KG, Lacayo NJ, Durán GE, Cohen D, Sikic BI.
    Mol Pharmacol; 2000 Apr 07; 57(4):769-77. PubMed ID: 10727524
    [Abstract] [Full Text] [Related]

  • 6. Effect of Calphostin C (PKC inhibitor) on daunorubicin resistance in P388/ADR and HL60/AR cells: reversal of drug resistance possibly via P-glycoprotein.
    Gupta S, Patel K, Singh H, Gollapudi S.
    Cancer Lett; 1994 Jan 30; 76(2-3):139-45. PubMed ID: 7511983
    [Abstract] [Full Text] [Related]

  • 7. Characterization of the azidopine and vinblastine binding site of P-glycoprotein.
    Bruggemann EP, Currier SJ, Gottesman MM, Pastan I.
    J Biol Chem; 1992 Oct 15; 267(29):21020-6. PubMed ID: 1356986
    [Abstract] [Full Text] [Related]

  • 8. The protein kinase C inhibitor CGP 41251, a staurosporine derivative with antitumor activity, reverses multidrug resistance.
    Utz I, Hofer S, Regenass U, Hilbe W, Thaler J, Grunicke H, Hofmann J.
    Int J Cancer; 1994 Apr 01; 57(1):104-10. PubMed ID: 7908658
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.
    Friche E, Demant EJ, Sehested M, Nissen NI.
    Br J Cancer; 1993 Feb 01; 67(2):226-31. PubMed ID: 8094288
    [Abstract] [Full Text] [Related]

  • 12. Partial reversal of multidrug resistance in human breast cancer cells by an N-myristoylated protein kinase C-alpha pseudosubstrate peptide.
    Gupta KP, Ward NE, Gravitt KR, Bergman PJ, O'Brian CA.
    J Biol Chem; 1996 Jan 26; 271(4):2102-11. PubMed ID: 8567666
    [Abstract] [Full Text] [Related]

  • 13. P-glycoprotein-mediated multidrug resistance is modulated by pretreatment with chemosensitizers in HCT-8 carcinoma cells in vitro.
    Haberl I, Swatonek H, Schaufler K, Ulsperger E, Wenzl E, Theyer G, Hamilton G, Thalhammer T.
    Int J Oncol; 1998 May 26; 12(5):1137-42. PubMed ID: 9538140
    [Abstract] [Full Text] [Related]

  • 14. Transport of the multidrug resistance modulators verapamil and azidopine in wild type and daunorubicin resistant Ehrlich ascites tumour cells.
    Sehested M, Skovsgaard T, Jensen PB, Demant EJ, Friche E, Bindslev N.
    Br J Cancer; 1990 Jul 26; 62(1):37-41. PubMed ID: 1975202
    [Abstract] [Full Text] [Related]

  • 15. Reversal of vinblastine resistance by a new staurosporine derivative, NA-382, in P388/ADR cells.
    Miyamoto K, Wakusawa S, Inoko K, Takagi K, Koyama M.
    Cancer Lett; 1992 Jun 15; 64(2):177-83. PubMed ID: 1351792
    [Abstract] [Full Text] [Related]

  • 16. Bile canalicular cationic dye secretion as a model for P-glycoprotein mediated transport.
    Thalhammer T, Stapf V, Gajdzik L, Graf J.
    Eur J Pharmacol; 1994 Apr 04; 270(2-3):213-20. PubMed ID: 7913684
    [Abstract] [Full Text] [Related]

  • 17. Modulation of P-glycoprotein by protein kinase C alpha in a baculovirus expression system.
    Ahmad S, Safa AR, Glazer RI.
    Biochemistry; 1994 Aug 30; 33(34):10313-8. PubMed ID: 7915139
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of multidrug resistance by a new staurosporine derivative, NA-382, in vitro and in vivo.
    Miyamoto K, Inoko K, Wakusawa S, Kajita S, Hasegawa T, Takagi K, Koyama M.
    Cancer Res; 1993 Apr 01; 53(7):1555-9. PubMed ID: 8095855
    [Abstract] [Full Text] [Related]

  • 19. Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesicles.
    Horio M, Lovelace E, Pastan I, Gottesman MM.
    Biochim Biophys Acta; 1991 Jan 09; 1061(1):106-10. PubMed ID: 1671642
    [Abstract] [Full Text] [Related]

  • 20. Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells.
    Nare B, Prichard RK, Georges E.
    Mol Pharmacol; 1994 Jun 09; 45(6):1145-52. PubMed ID: 7912815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.